102 related articles for article (PubMed ID: 10961691)
61. Radha Mohan Mishra.
Mishra B
BMJ; 2017 Mar; 356():j1144. PubMed ID: 28314723
[No Abstract] [Full Text] [Related]
62. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
[TBL] [Abstract][Full Text] [Related]
63. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D
Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608
[TBL] [Abstract][Full Text] [Related]
64. Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families.
Briguglio I; Piras S; Corona P; Carta A
Int J Med Chem; 2011; 2011():213135. PubMed ID: 27516903
[TBL] [Abstract][Full Text] [Related]
65. Discovering new medicines targeting helicases: challenges and recent progress.
Shadrick WR; Ndjomou J; Kolli R; Mukherjee S; Hanson AM; Frick DN
J Biomol Screen; 2013 Aug; 18(7):761-81. PubMed ID: 23536547
[TBL] [Abstract][Full Text] [Related]
66. Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase.
Hanson AM; Hernandez JJ; Shadrick WR; Frick DN
Methods Enzymol; 2012; 511():463-83. PubMed ID: 22713333
[TBL] [Abstract][Full Text] [Related]
67. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
[TBL] [Abstract][Full Text] [Related]
68. Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase.
Despins S; Issur M; Bougie I; Bisaillon M
Nucleic Acids Res; 2010 Sep; 38(16):5493-506. PubMed ID: 20421212
[TBL] [Abstract][Full Text] [Related]
69. Effects of mutagenic and chain-terminating nucleotide analogs on enzymes isolated from hepatitis C virus strains of various genotypes.
Heck JA; Lam AM; Narayanan N; Frick DN
Antimicrob Agents Chemother; 2008 Jun; 52(6):1901-11. PubMed ID: 18391043
[TBL] [Abstract][Full Text] [Related]
70. Structure-based mutational analysis of the NS3 helicase from dengue virus.
Sampath A; Xu T; Chao A; Luo D; Lescar J; Vasudevan SG
J Virol; 2006 Jul; 80(13):6686-90. PubMed ID: 16775356
[TBL] [Abstract][Full Text] [Related]
71. Unraveling the 'DEAD-box' helicases of Plasmodium falciparum.
Tuteja R; Pradhan A
Gene; 2006 Jul; 376(1):1-12. PubMed ID: 16713133
[TBL] [Abstract][Full Text] [Related]
72. Synthesis and characterization of the oxidized dGTP lesions spiroiminodihydantoin-2'-deoxynucleoside-5'- triphosphate and guanidinohydantoin-2'-deoxynucleoside-5'- triphosphate.
Ye Y; Muller JG; Burrows CJ
J Org Chem; 2006 Mar; 71(5):2181-4. PubMed ID: 16497015
[TBL] [Abstract][Full Text] [Related]
73. Viral and cellular RNA helicases as antiviral targets.
Kwong AD; Rao BG; Jeang KT
Nat Rev Drug Discov; 2005 Oct; 4(10):845-53. PubMed ID: 16184083
[TBL] [Abstract][Full Text] [Related]
74. Localisation of the human hSuv3p helicase in the mitochondrial matrix and its preferential unwinding of dsDNA.
Minczuk M; Piwowarski J; Papworth MA; Awiszus K; Schalinski S; Dziembowski A; Dmochowska A; Bartnik E; Tokatlidis K; Stepien PP; Borowski P
Nucleic Acids Res; 2002 Dec; 30(23):5074-86. PubMed ID: 12466530
[TBL] [Abstract][Full Text] [Related]
75. Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme.
Borowski P; Lang M; Haag A; Schmitz H; Choe J; Chen HM; Hosmane RS
Antimicrob Agents Chemother; 2002 May; 46(5):1231-9. PubMed ID: 11959550
[TBL] [Abstract][Full Text] [Related]
76. Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme.
Borowski P; Niebuhr A; Mueller O; Bretner M; Felczak K; Kulikowski T; Schmitz H
J Virol; 2001 Apr; 75(7):3220-9. PubMed ID: 11238848
[TBL] [Abstract][Full Text] [Related]
77. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy.
Borowski P; Mueller O; Niebuhr A; Kalitzky M; Hwang LH; Schmitz H; Siwecka MA; Kulikowsk T
Acta Biochim Pol; 2000; 47(1):173-80. PubMed ID: 10961691
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP).
Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T
Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782
[TBL] [Abstract][Full Text] [Related]
79. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
80. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
